{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T14:32:02Z","timestamp":1786717922162,"version":"build-2736575974"},"reference-count":12,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oman J Ophthalmol"],"published-print":{"date-parts":[[2016]]},"DOI":"10.4103\/0974-620x.192268","type":"journal-article","created":{"date-parts":[[2016,10,14]],"date-time":"2016-10-14T06:37:53Z","timestamp":1476427073000},"page":"150","source":"Crossref","is-referenced-by-count":24,"title":["A comparative study of various topical nonsteroidal anti-inflammatory drugs to steroid drops for control of post cataract surgery inflammation"],"prefix":"10.4103","volume":"9","author":[{"given":"Anu","family":"Malik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anup","family":"Sadafale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"YogeshKumar","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alka","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/0974-620X.192268-1","doi-asserted-by":"crossref","unstructured":"Flach AJ. Nonsteroidal anti-inflammatory drugs. In: Tasman W, editor. Duane\u2032s Foundations of Clinical Ophthalmology. Philadelphia, PA: Lippincott; 1994. p. 1-32.","DOI":"10.1097\/00004397-199303340-00003"},{"key":"key-10.4103\/0974-620X.192268-2","first-page":"751","volume-title":"Critical appraisal of ophthalmic ketorolac in treatment of pain and inflammation following cataract surgery","author":"Reddy","year":"2011","journal-title":"Clin Ophthalmol"},{"key":"key-10.4103\/0974-620X.192268-3","first-page":"505","volume-title":"Ocular effects of topical and systemic steroids","author":"Renfro","year":"1992","journal-title":"Dermatol Clin"},{"key":"key-10.4103\/0974-620X.192268-4","first-page":"1380","volume-title":"Effects of dexamethasone, diclofenac, or placebo on the inflammatory response after cataract surgery","author":"Laurell","year":"2002","journal-title":"Br J Ophthalmol"},{"key":"key-10.4103\/0974-620X.192268-5","first-page":"236","volume-title":"Topical diclofenac sodium compared with prednisolone acetate after phacoemulsification-lens implant surgery","author":"Demco","year":"1997","journal-title":"Eur J Ophthalmol"},{"key":"key-10.4103\/0974-620X.192268-6","doi-asserted-by":"crossref","unstructured":"el-Harazi SM, Ruiz RS, Feldman RM, Villanueva G, Chuang AZ. A randomized double-masked trial comparing ketorolac tromethamine 0.5%, diclofenac sodium 0.1%, and prednisolone acetate 1% in reducing post-phacoemulsification flare and cells. Ophthalmic Surg Lasers 1998;29:539-44.","DOI":"10.3928\/1542-8877-19980701-03"},{"key":"key-10.4103\/0974-620X.192268-7","first-page":"53","volume-title":"Nepafenac ophthalmic suspension 0.1% for the prevention and treatment of ocular inflammation associated with cataract surgery","author":"Lane","year":"2007","journal-title":"J Cataract Refract Surg"},{"key":"key-10.4103\/0974-620X.192268-8","unstructured":"Stewart WC, Stewart R, Maxwell WA. Preoperative and postoperative clinical evaluation of nepafenac 0.1% ophthalmic suspension for postcataract inflammation. Presented at: American Society of Cataract and Refractive Surgery; 18 April, 2005. Washington, DC; 2005."},{"key":"key-10.4103\/0974-620X.192268-9","doi-asserted-by":"crossref","unstructured":"Donnenfeld ED, Holland EJ, Stewart RH, Gow JA, Grillone LR; Bromfenac Ophthalmic Solution 0.09% (Xibrom) Study Group. Bromfenac ophthalmic solution 0.09% (Xibrom) for postoperative ocular pain and inflammation. Ophthalmology 2007;114:1653-62.","DOI":"10.1016\/j.ophtha.2006.12.029"},{"key":"key-10.4103\/0974-620X.192268-10","first-page":"276","volume-title":"Effect of bromfenac ophthalmic solution on ocular inflammation and corneal epithelial barrier function following cataract surgery","author":"Kawaguchi","year":"2003","journal-title":"Folia Ophthalmol Jpn"},{"key":"key-10.4103\/0974-620X.192268-11","first-page":"699","volume-title":"Comparison of the efficacy and safety of ketorolac tromethamine 0.5% and prednisolone acetate 1% after cataract surgery","author":"Simone","year":"1999","journal-title":"J Cataract Refract Surg"},{"key":"key-10.4103\/0974-620X.192268-12","doi-asserted-by":"crossref","unstructured":"Duong HV, Westfield KC, Chalkley TH. Ketorolac tromethamine LS 0.4% versus nepafenac 0.1% in patients having cataract surgery. Prospective randomized double-masked clinical trial. J Cataract Refract Surg 2007;33:1925-9.","DOI":"10.1016\/j.jcrs.2007.07.017"}],"container-title":["Oman Journal of Ophthalmology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T13:29:18Z","timestamp":1786714158000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/0974-620X.192268"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"references-count":12,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016]]}},"alternative-id":["192268"],"URL":"https:\/\/doi.org\/10.4103\/0974-620x.192268","relation":{},"ISSN":["0974-620X"],"issn-type":[{"value":"0974-620X","type":"print"}],"subject":[],"published":{"date-parts":[[2016]]}}}